Efficacy and Safety of TPC Induction Chemotherapy Combined With Nimotuzumab and Toripalimab "Immune Sandwich" Regimen Versus Full-Course Immunotherapy for Locally Advanced Nasopharyngeal Carcinoma
Clinical trial NCT07706985 · RECRUITING
Trial details
- NCT number
- NCT07706985
- Sponsor
- Sun Yat-sen University
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-07-20
- Primary completion
- 2030-07-20
- Enrollment
- 566
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.